|1.||Bogousslavsky, Julien: 2 articles (11/2011 - 01/2002)|
|2.||Inoie, Masukazu: 1 article (07/2014)|
|3.||Inoue, Mayuko: 1 article (07/2014)|
|4.||Tomizuka, Yosuke: 1 article (07/2014)|
|5.||Hayashi, Minoru: 1 article (07/2014)|
|6.||Ito, Hideaki: 1 article (07/2014)|
|7.||Nakano, Minoru: 1 article (07/2014)|
|8.||Muramatsu, Hideyuki: 1 article (07/2014)|
|9.||Yoshimoto, Shinya: 1 article (07/2014)|
|10.||Odo, Masashi: 1 article (01/2014)|
01/01/2005 - "Trafermin may promise to be an effective treatment for skin ulcers."
04/01/2007 - "In Japan, recombinant bFGF, also known as Trafermin, has been administered for intractable skin ulcer for its strong effect on tissue granulation. "
01/01/2005 - "To our knowledge, we report the first clinical use of trafermin in a patient with a skin ulcer resulting from auricular trauma. "
01/01/2005 - "Use of trafermin to treat a skin ulcer after repair of a deep auricular laceration: a case report."
01/01/2005 - "We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that developed after an extremely deep auricular laceration was sutured. "
|2.||Stomach Neoplasms (Stomach Cancer)
11/01/2012 - "Here, we provide a preliminary report of a case of intractable duodenal fistula successfully treated with Trafermin containing basic fibroblast growth factor. "
11/01/2012 - "[A novel treatment strategy using trafermin, containing basic fibroblast growth factor, for intractable duodenal fistula following curative gastrectomy for gastric cancer-case report and literature review]."
03/01/2012 - "Thus, clinical trials with trafermin in stroke are warranted but should be based on neuronal restoration rather than acute neuroprotection."
11/01/2011 - "A recombinant native form of human bFGF, trafermin, has been tested in Phase III clinical trials in patients with stroke. "
01/01/2002 - "A previous study in acute stroke patients suggested that trafermin was safe and well tolerated when given over a 3-hour period over a wide dose range. "
01/01/2002 - "Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial."
11/01/2011 - "Another randomized clinical trial is needed to test trafermin in stroke patients but to enhance functional recovery."
|5.||Hypotension (Low Blood Pressure)
|1.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|3.||Fibroblast Growth Factors (Fibroblast Growth Factor)
|5.||recombinant KCB-1 protein
|2.||Negative-Pressure Wound Therapy